Just bought Hikma Pharmaceuticals!
Ticker code is HIK
Hikma is a multinational drugs company they supply develop and manufacture both branded and unbranded drugs worldwide they started life in Jordan.
From what I have read they still have growth potential to come and here is a thing that shows promise also, have a look at the following website…
This shows all the companies ranked in order of their market cap – from this you can see that HIK is about to be moved up into the FTSE 100 this usually means that more funds etc buy in so should add support to the price (Hikma is above the automatic entry to FTSE 100 point at the time of writing) maybe by the time you are reading this it will be long established in the FTSE 100!
I first bought these back in November for another fund that I manage at around 1890 and now they are 2350 and still going
Listed on the FTSE 250
Market Cap 4681m GBP
Current Year Profit before tax ( For half year) 219m USD versus last full year PBT of 298m.
Net Debt was 175m USD at last report (so happy that this is less than 1 years profit)
Ratio of Market Cap to PBT is 13.5
Last results commented that revenue guidance was for 7% Growth
Next results are due on the 11th of March 2015
I notice that the last Directors Deal was a SELL of 155724 shares which left them with still over 11 million shares so I wouldn’t find that very worrying.
Possibility of Law suits but this is overridden in my view by the fact that it could well be promoted to the FTSE 100 as I mentioned Earlier.
Subscribe to keep up to date with all my trades!
Buy Price: 362p
Target Price: 500p
Stop Loss: 318p